Prediction of obstructive sleep apnoea in children and adolescents with Down syndrome

P R Wijayaratne1, K Williams1,2, M J Davey1,3

  • 1Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.

Insights

A new model accurately predicts moderate-severe obstructive sleep apnoea (OSA) in children with Down syndrome (DS). This tool uses the Pediatric Sleep Survey Instrument and actigraphy, potentially improving diagnosis and reducing the need for polysomnography (PSG).

Area of Science:

  • Pediatric Sleep Medicine
  • Genetics and Sleep Disorders
  • Diagnostic Tool Development

Background:

  • Obstructive sleep apnoea (OSA) is highly prevalent in children and adolescents with Down syndrome (DS).
  • Current clinical guidelines recommend polysomnography (PSG) for OSA assessment in children with DS by age 4.
  • Limited access to PSG and the burden of testing pose significant challenges for families.

Purpose of the Study:

  • To develop and validate a predictive model for moderate-to-severe OSA in children and adolescents with Down syndrome.
  • To identify key demographic, anthropometric, quality of life, and sleep-related variables for OSA prediction.
  • To establish a tool for triaging children with DS for PSG, improving diagnostic accessibility.

Main Methods:

  • Prospective cross-sectional cohort study design.
  • Utilized a comprehensive dataset including demographic, anthropometric, quality of life, and sleep-related variables.
  • Developed predictive models incorporating the Pediatric Sleep Survey Instrument (PSSI) and actigraphy-based sleep fragmentation.

Main Results:

  • A predictive model combining the PSSI sleep disordered breathing subscale and actigraphy-quantified sleep fragmentation demonstrated significant accuracy in identifying moderate-to-severe OSA.
  • The model achieved high sensitivity (82%), specificity (80%), positive predictive value (75%), and negative predictive value (86%).
  • This model effectively identifies children and adolescents with DS who have moderate/severe OSA.

Conclusions:

  • A validated tool incorporating the PSSI and actigraphy can effectively identify moderate-to-severe OSA in children and adolescents with Down syndrome.
  • This approach offers a promising alternative or adjunct to PSG for OSA screening in this population.
  • The findings support the utility of this tool in clinical practice for improved OSA management in children with DS.
Abstract

Related Concept Videos